Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma.

Literature DB >> 27740613

Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma.

M Mohammadi¹, M Goodarzi², M R Jaafari³, H R Mirzaei⁴, H Mirzaei⁵.

Abstract

Neuroblastoma (NB) is known as a pediatric neoplasm that is associated with variable histopathological features. The use of biomarkers contributes to the monitoring and treatment of various malignancies such as NB. The identification of novel biomarkers such as (epi)genetic biomarkers and microRNAs (miRNAs) in NB has led to better treatments of NB. Among them, miRNAs have emerged as powerful tools in diagnosis, prognosis and therapeutic biomarkers for patients with NB. Circulating biomarkers such as circulating miRNAs present in body fluids (for example, plasma, serum and urine) provided an interesting field of study in NB treatment. The miRNAs have central roles in different pathogenic events in various malignancies such as NB. Hence, these molecules can be a suitable candidate for monitoring and treating NB patients. Here, we summarize some miRNAs as potential prognosis, diagnosis and therapeutic biomarkers in NB.

Entities: Disease Species

Mesh：

Substances：

Year: 2016 PMID： 27740613 DOI： 10.1038/cgt.2016.45

Source DB: PubMed Journal: Cancer Gene Ther ISSN： 0929-1903 Impact factor: 5.987

8 in total

1. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.

Authors: Shizhen Zhu; Jeong-Soo Lee; Feng Guo; Jimann Shin; Antonio R Perez-Atayde; Jeffery L Kutok; Scott J Rodig; Donna S Neuberg; Daniel Helman; Hui Feng; Rodney A Stewart; Wenchao Wang; Rani E George; John P Kanki; A Thomas Look
Journal: Cancer Cell Date: 2012-03-20 Impact factor: 31.743

Review 2. Protein chip array profiling analysis of sera from neuroblastoma patients.

Authors: Valérie Combaret; Christophe Bergeron; Stéphanie Bréjon; Isabelle Iacono; David Perol; Sylvie Négrier; Alain Puisieux
Journal: Cancer Lett Date: 2005-10-18 Impact factor: 8.679

Review 3. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.

Authors: Hamed Mirzaei; Sharareh Gholamin; Soodabeh Shahidsales; Amirhossein Sahebkar; Mahmoud Reza Jaafari; Hamid Reza Mirzaei; Seyed Mahdi Hassanian; Amir Avan
Journal: Eur J Cancer Date: 2015-12-13 Impact factor: 9.162

Review 4. Molecular detection of micrometastases and circulating tumor cells in solid tumors.

Authors: R A Ghossein; S Bhattacharya; J Rosai
Journal: Clin Cancer Res Date: 1999-08 Impact factor: 12.531

Review 5. Neuroblastoma: biological insights into a clinical enigma.

Authors: Garrett M Brodeur
Journal: Nat Rev Cancer Date: 2003-03 Impact factor: 60.716

Review 6. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers.

Authors: Hamid Reza Mirzaei; Amirhossein Sahebkar; Mohsen Mohammadi; Reza Yari; Hossein Salehi; Mohammad Hasan Jafari; Afshin Namdar; Ehsan Khabazian; Mahmoud Reza Jaafari; Hamed Mirzaei
Journal: Curr Pharm Des Date: 2016 Impact factor: 3.116

Review 7. Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.

Authors: Reza Salarinia; Amirhossein Sahebkar; Mostafa Peyvandi; Hamid Reza Mirzaei; Mahmoud Reza Jaafari; Maryam Matbou Riahi; Hamed Ebrahimnejad; Javid Sadri Nahand; Jamshid Hadjati; Mobina Ostadi Asrami; Sara Fadaei; Rasoul Salehi; Hamed Mirzaei
Journal: Curr Cancer Drug Targets Date: 2016 Impact factor: 3.428

Review 8. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment.

Authors: Sharareh Gholamin; Alireza Pasdar; Mohammad Sadegh Khorrami; Hamed Mirzaei; Hamid Reza Mirzaei; Rasoul Salehi; Gordon A Ferns; Majid Ghayour-Mobarhan; Amir Avan
Journal: Curr Pharm Des Date: 2016 Impact factor: 3.116

8 in total

11 in total

Review 1. The Story of Nanoparticles in Differentiation of Stem Cells into Neural Cells.

Authors: Vajihe Asgari; Amir Landarani-Isfahani; Hossein Salehi; Noushin Amirpour; Batool Hashemibeni; Saghar Rezaei; Hamid Bahramian
Journal: Neurochem Res Date: 2019-11-12 Impact factor: 3.996

2. NEAT1 in bone marrow mesenchymal stem cell-derived extracellular vesicles promotes melanoma by inducing M2 macrophage polarization.

Authors: Yemei Yang; Shengfang Ma; Zi Ye; Yushi Zheng; Zhenjiong Zheng; Xiongshan Liu; Xianyi Zhou
Journal: Cancer Gene Ther Date: 2022-02-03 Impact factor: 5.854

Review 3. MiRNA Influences in Neuroblast Modulation: An Introspective Analysis.

Authors: Vanessa Zammit; Byron Baron; Duncan Ayers
Journal: Genes (Basel) Date: 2018-01-09 Impact factor: 4.096

4. Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion.

Authors: Weiyi Li; Jing Cao; Jian Liu; Wenli Chu; Congqing Zhang; Shuiling Chen; Zefeng Kang
Journal: Cell Mol Biol Lett Date: 2019-03-07 Impact factor: 5.787

5. miR-181c expression in neuroblastoma children and proliferation of neuroblastoma M17 cells.

Authors: Xueyan Xu; Jun Wu; Guifang Ren; Qiang Hu
Journal: Oncol Lett Date: 2019-07-11 Impact factor: 2.967

6. Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma.

Authors: Barbara Marengo; Alessandra Pulliero; Maria Valeria Corrias; Riccardo Leardi; Emanuele Farinini; Gilberto Fronza; Paola Menichini; Paola Monti; Lorenzo Monteleone; Giulia Elda Valenti; Andrea Speciale; Patrizia Perri; Francesca Madia; Alberto Izzotti; Cinzia Domenicotti
Journal: J Pers Med Date: 2021-02-07

7. FGFR1 is a potential therapeutic target in neuroblastoma.

Authors: Flora Cimmino; Annalaura Montella; Matilde Tirelli; Marianna Avitabile; Vito Alessandro Lasorsa; Feliciano Visconte; Sueva Cantalupo; Teresa Maiorino; Biagio De Angelis; Martina Morini; Aurora Castellano; Franco Locatelli; Mario Capasso; Achille Iolascon
Journal: Cancer Cell Int Date: 2022-04-29 Impact factor: 6.429